Molecular Biology of Retinitis Pigmentosa: Therapeutic Implications

Publisher： Bentham Science Publishers

E-ISSN： 1875-6204|2|4|339-349

ISSN： 1570-1603

Source： Current Pharmacogenomics, Vol.2, Iss.4, 2004-12, pp. : 339-349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic developments in cytomegalovirus retinitis

By Hoffman V.F.   Skiest D.J.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 2, 2000-02 ,pp. : 207-220

Informa Healthcare

Access to resources Recommend Favorite

Oxaliplatin: First report of worsened retinitis pigmentosa: case report

By  

Reactions Weekly, Vol. 1, Iss. 1400, 2012-01 ,pp. : 32-32

Adis International

Access to resources Recommend Favorite

RPGR and RP2: targets for the treatment of X-linked retinitis pigmentosa?

By Veltel Stefan   Wittinghofer Alfred  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 10, 2009-10 ,pp. : 1239-1251

Informa Healthcare

Access to resources Recommend Favorite

Intracompartmental Delivery of CNTF as Therapy for Huntingtons Disease and Retinitis Pigmentosa

By  

Current Gene Therapy, Vol. 6, Iss. 1, 2006-02 ,pp. : 147-159

Bentham Science Publishers

Access to resources Recommend Favorite

ET-1 plasma levels and ocular blood flow in retinitis pigmentosa

By Cellini Mauro   Strobbe Ernesto   Gizzi Corrado   Campos Emilio C.  

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 6, 2010-06 ,pp. : 630-635

NRC Research Press

Access to resources Recommend Favorite